mirtazapine has been researched along with Obesity, Morbid in 2 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
Obesity, Morbid: The condition of weighing two, three, or more times the ideal weight, so called because it is associated with many serious and life-threatening disorders. In the BODY MASS INDEX, morbid obesity is defined as having a BMI greater than 40.0 kg/m2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Mirtazapine is a noradrenergic and specific serotonergic antidepressant, which blocks the 5HT3 receptor, leading to an antiemetic effect." | 1.33 | Mirtazapine (Remeron) as treatment for non-mechanical vomiting after gastric bypass. ( Breda, MF; Novaretti, TM; Pereira, PG; Pilon, B; Teixeira, FV, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Teixeira, FV | 1 |
| Novaretti, TM | 1 |
| Pilon, B | 1 |
| Pereira, PG | 1 |
| Breda, MF | 1 |
| Huerta, S | 1 |
| Siddiqui, A | 1 |
2 other studies available for mirtazapine and Obesity, Morbid
| Article | Year |
|---|---|
Mirtazapine (Remeron) as treatment for non-mechanical vomiting after gastric bypass.
Topics: Adrenergic alpha-Antagonists; Adult; Female; Gastric Bypass; Humans; Mianserin; Mirtazapine; Obesity | 2005 |
Intractable nausea and vomiting following Roux-en-Y gastric bypass: role of mirtazapine.
Topics: Adult; Antiemetics; Female; Gastric Bypass; Histamine H1 Antagonists; Humans; Mianserin; Mirtazapine | 2006 |